Flen Pharma is a dynamic, independent Belgian company specialized in developing innovative and advanced treatments.

Our products and research are dedicated to improve quality of life through the development and marketing of affordable products for the treatment of inflammatory and infectious disorders.

Flen Pharma was established in November 2000, building on the results of wound-treatment research performed by its managing director Philippe Sollie, a pharmacist, during the 1990s. Flen Pharma is a privately owned company.
Flen Pharma's products for wound healing are based on the moist-wound healing principle and originate from patented polymer applications and patented enzyme complexes.
Its products - Flaminal® Forte, Flaminal® Hydro, Flamigel®, Flamispray®, Flamirins® and Flamiclens® - are registered within the EU as well as in China, Switzerland and Saudi Arabia.
Its first line of products is in wound care. New products are in development in dematological and related fields.
With laboratories and offices in Kontich, Flen Pharma applies ISO 13485 : 2003 quality standards to its operations.